Market's Perception of EXPE Stock as it Declines

Expedia stock is trading -16.71% below its average target price of $157.3 after dropping -17.8% during today's afternoon session. Analysts are giving the large-cap Integrated Freight & Logistics company an average rating of buy and target prices ranging from $100.0 to $200.0 per share.

The stock has an average amount of shares sold short at 4.8%, and a short ratio of 2.52. The company's insiders own 0.52% of its outstanding shares, which indicates a strong alignment between management and shareholder interests. Finally, we also note that a significant number of institutional investors are invested in the stock, with 98.5% of Expedia's shares being owned by this investor type.

Institutions Invested in Expedia

Date Reported Holder Percentage Shares Value
2023-09-30 Vanguard Group Inc 12% 15,851,662 $2,076,726,151
2023-09-30 Blackrock Inc. 8% 10,258,264 $1,343,935,110
2023-09-30 Morgan Stanley 7% 9,282,210 $1,216,062,281
2023-09-30 State Street Corporation 4% 5,429,650 $711,338,416
2023-09-30 Amundi 3% 4,580,575 $600,101,105
2023-09-30 Artisan Partners Limited Partnership 3% 4,364,108 $571,741,765
2023-09-30 JP Morgan Chase & Company 3% 3,611,929 $473,198,798
2023-09-30 Par Capital Management Inc 3% 3,450,000 $451,984,481
2023-09-30 Geode Capital Management, LLC 2% 3,145,957 $412,151,809
2023-09-30 Alkeon Capital Management LLC 2% 3,064,810 $401,520,741

Besides an analyst consensus of some upside potential, other market factors point to there being mixed market sentiment on Expedia.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.